The Department of Obstetrics and Gynecology established the EVA trial biobank with the aim of enabling scientific research into high blood pressure in pregnancy to improve the diagnosis, treatment and prognosis of patients in the future. The EVA trial biobank contains biomaterial (serum, EDTA- and citrate plasma) and specific data from the participating patient’s medical record.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
New business model for the Radboud Biobank
24 November 2024The Radboudumc Board of Directors decided, after receiving advice from the UMC council, to change the Radboud Biobank business model.
read morePlanning requests for samples
24 November 2024To avoid disappointment when requesting samples in peak periods, we strongly advise waiting for the Radboud Biobank planning before scheduling laboratory tests and analyses.
read moreNational Biobanks & Collections Day 2025
24 November 2024The second edition of the Biobanks & Collection Day will take place on 27th of March in the Auditorium at Radboudumc in Nijmegen.
read moreDevelopment of a new Dutch biobank standard
24 November 2024In 2023, within the framework of Health-RI Theme Biobanks & Collections, a team of biobankers initiated the development of a novel Dutch biobanking standard.
read moreIntroducing Wesley van Bronckhorst
24 November 2024My name is Wesley van Bronckhorst, and I recently started as an analyst at the Radboud Biobank.
read moreNational Biobanks & Collections day
19 October 2023The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.
read more